BridgeMD
New treatment option for Primary Progressive Aphasia(PPA)
Official title Intervention for Communication Quality of Life in Primary Progressive Aphasia
ClinicalTrials.gov ID: NCT07219680
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn whether a personalized, multi-component, virtual speech language treatment program can improve communication and quality of life for adults with primary progressive aphasia (PPA) and their primary communication partners. The study will enroll participants who speak English and/or Spanish.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 and older
You may be able to join if
- for Persons with PPA:
- A PPA (Gorno-Tempini et al., 2011) or "PPA-plus" (Mesulam et al., 2001) diagnosis
- MMSE score of 15 or higher and must be able to produce single monosyllabic words intelligibly
- Must speak English, Spanish or both languages (i.e., bilingual speakers of English or Spanish)
- Hearing and vision adequate for participation in teleconference meetings
You likely can't join if
- for persons with PPA:
- Other central nervous system or medical diagnosis that can account for symptoms
- Psychiatric diagnosis that can account for symptoms
See the full eligibility criteria
- for Persons with PPA:
- A PPA (Gorno-Tempini et al., 2011) or "PPA-plus" (Mesulam et al., 2001) diagnosis
- MMSE score of 15 or higher and must be able to produce single monosyllabic words intelligibly
- Must speak English, Spanish or both languages (i.e., bilingual speakers of English or Spanish)
- Hearing and vision adequate for participation in teleconference meetings
- Must have a study partner available (someone who will commit to attending teleconference sessions, as needed, during assessment and treatment phases) for Care Partners:
- Partners must express willingness to attend and participate in assessment and treatment sessions, including those targeting dyadic communication goals
- Partners must speak English, Spanish or both languages (i.e., bilingual speakers of English or Spanish)
- Partner's hearing and vision should be adequate for participation in teleconference meetings The participant and/or study partner must have basic experience using a computer.
- for persons with PPA:
- Other central nervous system or medical diagnosis that can account for symptoms
- Psychiatric diagnosis that can account for symptoms
The study team makes the final eligibility decision.
Where it's taking place
- Austin, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Austin, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.